![](/documents/10803/17059027/ri-duo-emploi-internship-program-thumbnail.jpg/ce0bdeb9-9617-33e8-1c57-55a92db8d028?t=1722011987106)
RI-MUHC embraces inclusivity with Duo Emploi Internship Program
For the second year in a row, researchers, trainees and staff welcomed interns with disabilities, fostering an inclusive environment through...
![](/documents/10803/17059027/ri-researchers-honoured-prestigious-crc-thumbnail.jpg/f00f3802-1daa-fcfc-029e-2a5c2faab33d?t=1721917552883)
Three RI-MUHC researchers honoured with prestigious Canada Research Chairs
Sylvie Lambert, Marc Martel and Mathieu Roy are emerging leaders in research domains ranging from chronic illnesses...
![](/documents/10803/17046930/triple-negative-breast-cancer-new-hope-thumbnail.jpg/391c78e1-1248-c89f-90dd-4536db25ebb4?t=1721831057555)
Triple-negative breast cancer: new hope for an existing drug
RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...
![](/documents/10803/17046930/marathon-hope-cancer-centres-network-funding-thumbnail.jpg/872d8e02-6cf5-44b6-f548-2745ce52c536?t=1721753972996)
Prescribing personalized lifestyle interventions to improve prostate cancer treatments
David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...
![](/documents/10803/17046930/jabado-research-therapeutic-target-thumbnail.png/e83b6069-9a81-b257-f43d-0799fa333865?t=1720627005710)
Researchers find a possible therapeutic target in the “genetic landscape” of aggressive and deadly pediatric brain tumours
A new study reveals that PFA ependymoma brain tumours display...
![](/documents/10803/17046930/major-funding-awards-ri-trainees-thumbnail.png/2f14196b-7950-f83a-7363-4e7657b33521?t=1720020095337)
Major funding awards for seven RI-MUHC trainees
A Banting Fellowship and six Vanier Scholarships were awarded in 2024
![](/documents/10803/17001739/increasing-clinical-trial-expertise-ri-thumbnail.jpg/0a476054-7af3-b898-ee69-87f3cebbf66d?t=1719492467731)
Increasing clinical trial expertise at the RI-MUHC
The RI-MUHC ACT-CTU reports on the realization of its vision for 2024 to build a clinical trials community and strengthen trial capabilities at the RI-MUHC
![](/documents/10803/16967537/ri-researchers-precision-medicine-cancer-thumbnail.jpg/5a8fa6fa-77fb-ff4d-49ad-6287dafa008b?t=1718635866712)
RI-MUHC researchers work to accelerate precision medicine for cancer in Canada
Three additional RI-MUHC research projects funded by the Marathon of Hope Cancer Centres Network
![](/documents/10803/16967537/2024-clic-winners-finalists-thumbnail.jpg/c1ec7a19-eb9d-3cc7-7067-4ca88885b230?t=1718373400898)
Congratulations to our 2024 CLIC winners and finalists
RI-MUHC researchers and trainees collaborate on four winning teams
![](/documents/10803/17001739/ri-study-ai-understand-liver-cancer-thumbnail.jpg/21c8aa8b-8330-f554-49fb-64152fe8788b?t=1718282867765)
RI-MUHC study uses AI to understand liver cancer
A new publication describes the use of ALiX, a unique AI model, to analyze data from liquid biopsy